Literature DB >> 33751359

Trelagliptin Alleviates Lipopolysaccharide (LPS)-Induced Inflammation and Oxidative Stress in Acute Lung Injury Mice.

Jia Zhou1, Zhengliang Peng1, Jian Wang2.   

Abstract

Acute lung injury (ALI) is an urgent disease lacking effective therapies, resulting in relatively high morbidity and mortality. The pathological mechanism of ALI is reported to be related to excessive inflammation and activated oxidative stress. The present study aims to investigate the protective effects of the DPP-4 inhibitor Trelagliptin against lipopolysaccharide (LPS)-induced ALI and the underlying mechanism. LPS was used to induce ALI mice models. The pathological condition of ALI mice was evaluated using MPO activity assay, lung wet to dry weight ratio detection, and HE staining on the lung tissues. Lung function was assessed using a spirometer. The oxidative stress level in the lung tissues was checked by MDA measurement and GPx detection using commercial kits. The leukocyte and neutrophil numbers were determined using a hemocytometer and the total concentration of protein in the BALF was detected using a bicinchoninic acid method. The expression levels of TNF-α, IL-6, and CXCL2 in the lung tissues were evaluated using qRT-PCR and ELISA. Western blot analysis was used to determine the expression levels of TLR4 and p-NF-κB p65. LPS-induced elevated MPO activity, pulmonary wet to dry weight ratio, airway resistance (RAW), the total number of leukocytes and neutrophils, production of inflammatory factors, decreased pulmonary dynamic compliance (Cdyn), and peak expiratory flow (PEF), and an aggravated histopathological state (such as disordered alveolar structure, significant pulmonary interstitial edema, and large numbers of red blood cells and inflammatory cells in the alveolar cavity) were significantly reversed by the administration of Trelagliptin. The TLR4/NF-κB signaling pathway was activated and oxidative stress was induced by stimulation with LPS; however, both effects were suppressed by the administration of Trelagliptin. Trelagliptin might alleviate LPS-induced inflammation and oxidative stress in acute lung injury mice.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Acute lung injury; Inflammation; LPS; NF-κB; Oxidative stress; Trelagliptin

Mesh:

Substances:

Year:  2021        PMID: 33751359     DOI: 10.1007/s10753-021-01435-w

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  33 in total

1.  Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study.

Authors:  Ognjen Gajic; Ousama Dabbagh; Pauline K Park; Adebola Adesanya; Steven Y Chang; Peter Hou; Harry Anderson; J Jason Hoth; Mark E Mikkelsen; Nina T Gentile; Michelle N Gong; Daniel Talmor; Ednan Bajwa; Timothy R Watkins; Emir Festic; Murat Yilmaz; Remzi Iscimen; David A Kaufman; Annette M Esper; Ruxana Sadikot; Ivor Douglas; Jonathan Sevransky; Michael Malinchoc
Journal:  Am J Respir Crit Care Med       Date:  2010-08-27       Impact factor: 21.405

Review 2.  Acute Respiratory Distress Syndrome.

Authors:  B Taylor Thompson; Rachel C Chambers; Kathleen D Liu
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

3.  A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury.

Authors:  Robert Paine; Theodore J Standiford; Ronald E Dechert; Marc Moss; Gregory S Martin; Andrew L Rosenberg; Victor J Thannickal; Ellen L Burnham; Morton B Brown; Robert C Hyzy
Journal:  Crit Care Med       Date:  2012-01       Impact factor: 7.598

4.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

Review 5.  Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment.

Authors:  Eddy Fan; Daniel Brodie; Arthur S Slutsky
Journal:  JAMA       Date:  2018-02-20       Impact factor: 56.272

Review 6.  Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis.

Authors:  Kentaro Iwata; Asako Doi; Goh Ohji; Hideaki Oka; Yuichiro Oba; Kohei Takimoto; Wataru Igarashi; David H Gremillion; Toshihiko Shimada
Journal:  Intern Med       Date:  2010-11-15       Impact factor: 1.271

7.  Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

Authors:  R P Dellinger; J L Zimmerman; R W Taylor; R C Straube; D L Hauser; G J Criner; K Davis; T M Hyers; P Papadakos
Journal:  Crit Care Med       Date:  1998-01       Impact factor: 7.598

8.  Incidence and outcomes of acute lung injury.

Authors:  Gordon D Rubenfeld; Ellen Caldwell; Eve Peabody; Jim Weaver; Diane P Martin; Margaret Neff; Eric J Stern; Leonard D Hudson
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

Review 9.  Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis.

Authors:  John Victor Peter; Preeta John; Petra L Graham; John L Moran; Ige Abraham George; Andrew Bersten
Journal:  BMJ       Date:  2008-04-23

10.  Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group.

Authors:  A Anzueto; R P Baughman; K K Guntupalli; J G Weg; H P Wiedemann; A A Raventós; F Lemaire; W Long; D S Zaccardelli; E N Pattishall
Journal:  N Engl J Med       Date:  1996-05-30       Impact factor: 91.245

View more
  2 in total

1.  Chrysosplenol D protects mice against LPS-induced acute lung injury by inhibiting oxidative stress, inflammation, and apoptosis via TLR4-MAPKs/NF-κB signaling pathways.

Authors:  Qinqin Zhang; Aozi Feng; Mengnan Zeng; Beibei Zhang; Jingya Shi; Yaxin Lv; Bing Cao; Chenxin Zhao; Mengya Wang; Yifan Ding; Xiaoke Zheng
Journal:  Innate Immun       Date:  2021-11-20       Impact factor: 2.680

2.  Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury via the TLR4/NF-κB Pathway.

Authors:  Xiao-Qin Qu; Qiong-Feng Chen; Qiao-Qing Shi; Qian-Qian Luo; Shuang-Yan Zheng; Yan-Hong Li; Liang-Yu Bai; Shuai Gan; Xiao-Yan Zhou
Journal:  Front Immunol       Date:  2022-07-08       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.